Department of Pathology, The Ohio State University Wexner Medical Center, E409 Doan Hall, 410 West 10th Ave, Columbus, OH, 43210, USA.
Diagn Pathol. 2023 Oct 3;18(1):109. doi: 10.1186/s13000-023-01375-z.
Digital pathology (DP) is being increasingly employed in cancer diagnostics, providing additional tools for faster, higher-quality, accurate diagnosis. The practice of diagnostic pathology has gone through a staggering transformation wherein new tools such as digital imaging, advanced artificial intelligence (AI) algorithms, and computer-aided diagnostic techniques are being used for assisting, augmenting and empowering the computational histopathology and AI-enabled diagnostics. This is paving the way for advancement in precision medicine in cancer. Automated whole slide imaging (WSI) scanners are now rendering diagnostic quality, high-resolution images of entire glass slides and combining these images with innovative digital pathology tools is making it possible to integrate imaging into all aspects of pathology reporting including anatomical, clinical, and molecular pathology. The recent approvals of WSI scanners for primary diagnosis by the FDA as well as the approval of prostate AI algorithm has paved the way for starting to incorporate this exciting technology for use in primary diagnosis. AI tools can provide a unique platform for innovations and advances in anatomical and clinical pathology workflows. In this review, we describe the milestones and landmark trials in the use of AI in clinical pathology with emphasis on future directions.
数字病理学(DP)正越来越多地应用于癌症诊断,为更快、更高质量、更准确的诊断提供了额外的工具。诊断病理学的实践发生了惊人的转变,新的工具,如数字成像、先进的人工智能(AI)算法和计算机辅助诊断技术,正被用于辅助、增强和赋能计算组织病理学和 AI 辅助诊断。这为癌症精准医学的发展铺平了道路。自动化全切片成像(WSI)扫描仪现在可以提供诊断质量的高分辨率全玻片图像,将这些图像与创新的数字病理学工具相结合,使得将成像集成到病理学报告的各个方面成为可能,包括解剖学、临床和分子病理学。最近 FDA 批准 WSI 扫描仪用于初级诊断以及前列腺 AI 算法的批准,为开始将这项令人兴奋的技术纳入初级诊断铺平了道路。人工智能工具可以为解剖学和临床病理学工作流程的创新和进步提供独特的平台。在这篇综述中,我们描述了人工智能在临床病理学中的应用的里程碑和标志性试验,并强调了未来的方向。